Topics:
Myocardial Disease
Current versions available to download
Authors
B. J. Maron and W. J. McKenna (Chairpersons), G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, E. D. Wigle
Endorsed by:
Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
|
Introduction:
Organization of committee and evidence review, Purpose of this Expert Consensus Document
|
|
General considerations and perspectives
|
|
Nomenclature, definitions, and clinical diagnosis
|
|
Obstruction to LV Outflow
|
| Genetics and molecular diagnosis |
| General considerations for natural history, and clinical course |
Symptoms and pharmacological management strategies:
Beta-adrenergic blocking agents, Verapamil, Disopyramide, Drugs in end-stage phase, Asymptomatic patients, Infective endocarditis prophylaxis, Pregnancy |
|
Treatment options for drug-refractory patients
|
|
Additional approaches to relieve outflow obstruction and symptoms:
Dual-chamber pacing, Percutaneous alcohol septal ablation
|
|
Sudden Cardiac Death:
Risk stratification, Prevention, Athlete recommendations
|
|
Atrial Fibrillation
|
Previous versions
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available
here